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SUBVERSION  OF HOST DEFENSE  MECHANISMS 
BY MURINE TUMORS 
II.  Counter-Influence of Concomitant Antitumor Immunity* 
BY  ROBERT  J.  NORTH,  DAVID P.  KIRSTEIN,  AND RICHARD L.  TUTTLE 
It was shown in the preceding paper (1) that subcutaneous injection of cells of any one 
of five unselected  murine  tumors  resulted  within 24  h  in the  presence  of a  factor in 
circulation that severely suppressed the ability of mice to resist experimental infection 
with Listeria monocytogenes and Yersinia enterocolitica. It was suggested, on the basis of 
the  knowledge  (2)  that  both native  and  acquired  resistance  to Listeria  infection  are 
expressed by macrophages, that the tumor-suppressor factor exerted its effect by either 
directly or  indirectly interfering with  the  function  of these  phagocytic cells.  It  was 
suggested, in turn, that the evidence is consistent with the proposition that at least some 
malignant cells are naturally selected to avoid destruction by a  macrophage-mediated 
mechanism of native antitumor resistance. Obviously, this view would have more cred- 
ence if it were shown that mice with suppressed antibacterial resistance displayed at the 
same time a  reduced capacity to resist the growth of a  challenge of tumor cells. 
Again,  the  preceding paper  only dealt  with  the  events  that  immediately followed 
injection of transplantable tumor cells. It remained a possibility, therefore, that suppres- 
sion of antibacterial resistance is only a  short-term  effect of tumor cell  implantation. 
Indeed,  this  could be  suggested on  the  grounds  that  it is by  no  means  a  commonly 
reported finding that death from  acute natural  infection is a  consequence  of injecting 
experimental animals with tumor cells. On the contrary, there is a recent demonstration 
(3) that mice bearing the Lewis lung carcinoma display increased resistance to Candida 
albicans infection. 
The  purpose  of this  paper  is  to  show  that  the  state  of severely  impaired 
antibacterial  resistance  which  immediately  follows subcutaneous  injection of 
murine  tumor  cells is short lived,  in that  it is soon replaced by a  contrasting 
state  of greatly  increased  antibacterial  resistance;  in  spite  of the  continuous 
presence  of the  suppressor factor in circulation.  Evidence  will be presented  to 
show  that  the  tumor-induced  states  of decreased  and  increased  antibacterial 
resistance  correspond  to  states  of decreased  and  increased  resistance  to  the 
tumor  itself. Consequently,  the results support the proposition that  antibacte- 
rial and antitumor  resistance are expressed by a common defense mechanism. 
Materials  and  Methods 
The materials and methods employed were the same as those employed in the preceding paper 
(1) except for additional procedures that were used to measure resistance to a tumor cell challenge. 
Antitumor Resistance.  Mice bearing a progressive subcutaneous tumor in the right-hind foot 
pad were compared with normal control mice in terms of their capacity to resist the growth of 
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either a  subcutaneous or intraperitoneal challenge  of tumor cells.  Resistance to  subcutaneous 
tumor cell challenge at progressive times during growth of the primary tumor was determined by 
measuring the growth of a standard number of tumor cells injected into the contralateral foot pad. 
The cells were injected in a vol of 0.05 ml of phosphate-buffered saline (PBS), j and tumor growth 
was  monitored by measuring changes in the dorso-ventral thickness of the foot pad  with dial 
calipers. 
Changes in resistance to growth of an intraperitoneal challenge of tumor cells was determined 
by measuring changes in the quantity of tritiated thymidine ([3H]TdR)  incorporated into total 
peritoneal cell DNA according to a published method (4). This involved challenging mice intraper- 
itoneally with a  standard dose of tumor cells in a vol of 0.2 ml of PBS at progressive times during 
the growth of the primary subcutaneous tumor.  At 24-h intervals over the next 3 days the mice 
were  given a  single  intravenous pulse  of 20  /iCi  [3H]TdR of sp act  3  Ci/mmol  (New  England 
Nuclear, Boston, Mass.).  30 min later, the peritoneal cells were harvested in 3 ml of heparinized 
PBS in a  standard fashion, washed two times over a  period of 1 h  in ice-cold 5% TCA, and then 
extracted  for  1  h  in  2  ml  of hot  (90°C)  TCA.  3H-DNA  in  the  extract  was  counted  by  liquid 
scintillation spectrometry. 
Results 
Conversion  from  Suppressed  to  Enhanced  Antibacterial  Resistance  during 
Tumor Growth.  The preceding paper showed (1) that subcutaneous injection of 
tumor cells resulted in rapid suppression of resistance to intravenous Listeria 
infection. The following experiments were designed to determine whether this 
state of severely suppressed antibacterial resistance persists during subsequent 
growth of the primary tumor. The experiment consisted of injecting semisynge- 
neic mice subcutaneously with  106 SA1,  P-815 mastocytoma,  or Meth A  cells, 
and measuring the capacity of the mice at progressive times thereafter to resist 
a  standard  5  ×  103  intravenous  Listeria  challenge  infection.  Antibacterial 
resistance  was  expressed  as  the  loglo  difference  between  the  growth  of the 
challenge organism in the livers of tumor-bearing mice and its growth in livers 
of control mice at 24 h of infection. 
The results in Fig. 1 reveal, in agreement with those in the preceding study, 
that subcutaneous injection of tumor cells quickly resulted in a state of severely 
suppressed antibacterial resistance. It can be seen in addition, however, that the 
state of negative resistance rapidly waned after 24 h, and was soon replaced by a 
contrasting  state  of greatly  increased  antibacterial  resistance.  The  speed  at 
which  this  conversion  from  suppressed  to  enhanced  antibacterial  resistance 
occurred, moreover, was related to the rate of growth of the primary tumor. The 
experiments were terminated  when the condition of the mice had deteriorated 
because of the massiveness of the primary tumors. 
To exclude the possibility that conversion from negative to positive antibacte- 
rial resistance was the unlikely result of a nonimmunological response of the F1 
hybrid against parental  tumor cells, the same experiment was performed with 
syngeneic mice.  That  syngeneic A/J mice injected with 106 SA1 cells gave the 
same results is shown in Fig. 2. 
Comparison  between States  of Negative  and Positive Antibacterial  Resist- 
ance.  The meaning,  in terms of overall resistance to infection, of the states of 
negative and  positive resistance  as revealed by the 24-h growth assay shown 
1 Abbreviations  used  in  this  paper:  [3H]TdR,  tritiated  thymidine;  PBS,  phosphate-buffered 
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FIG.  1.  Changes in resistance to Listeria  infection (bar graphs) during growth of three 
murine  tumors  in  semisyngeneic  mice.  Subcutaneous  implantation  of tumor  cells  first 
resulted  in a  state  of severely  suppressed  resistance and then in a  contrasting state  of 
enhanced resistance. Resistance is expressed as the loglo difference between the 24-h growth 
of the organism in livers of control and tumor-implanted mice. Means of five mice per time 
point. 
above is more convincingly demonstrated in Fig. 3, which compares the 2-day 
growth of Listeria in the livers of 1-day and 9-day tumor bearers. It can be seen 
that whereas a 2 x  103 Listeria inoculum showed enhanced growth for 2 days in 
the livers of 1-day tumor bearers, no bacterial growth occurred in the livers of 9- 
day tumor bearers. Thus while 1-day tumor bearers were highly susceptible to 
infection, 9-day tumor bearers were highly resistant. 
Presence of Suppressor Factor in Circulation in Spite of Acquisition of En- 
hanced Antibacterial Resistance.  It is known (1) that the short-term state of 
suppressed antibacterial resistance that rapidly follows injection of tumor cells 
is mediated by a  small molecular weight factor in circulation. To determine 
whether the production of this molecule continues in spite of the change from 
suppressed to enhanced antibacterial resistance, an experiment was performed 
to test for its presence in serum during a 9 day period of tumor growth. Thus, 
serum obtained from (AB6)F1 donor mice at progressive intervals after initiat- 
ing  a  subcutaneous tumor  with  106  SA1  cells  was tested for its  capacity to ROBERT  J. 
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Same experiment as Fig.  1, but in syngeneic mice. 
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FIG. 3.  Additional  evidence for conversion from suppressed  to enhanced antibacterial 
resistance during subcutaneous growth of an SA1 tumor. The liver growth curves show that 
whereas 1-day tumor bearers allowed enhanced growth of a sublethal Listeria  challenge for 
a 2 day period, 9-day tumor bearers were highly resistant to the same challenge. Means ± 2 
SE of five mice per time point. 
suppress  anti-Listeria  resistance  when infused  into  normal recipients.  Serum 
was injected intraperitoneally in a vol of 0.2 ml 1 h before intravenous challenge 
with 2  ×  10  ~ Listeria.  Bacterial growth was measured by the 24-h growth assay 
employed in a  preceding  section. 
Fig.  4 shows that an infusion of 0.2 ml of serum collected at any time during 
growth of the primary tumor was able to significantly suppress the antibacterial 
resistance of normal recipients.  It will be noted, however, that there was a  drop 
in the potency of the serum after about the 5th day of tumor growth, i.e.,  after 
the  conversion  from  negative  to  positive  antibacterial  resistance  (Fig.  1).  In- 
deed, the resuts of a limiting dilution assay employed in the preceding paper (1) 
indicate that this drop may have represented  as much as a  50-fold reduction in 
concentration of the suppressor factor. 
Nevertheless,  when sera from 1-day tumor-bearing donors and 9-day tumor- 
bearing  donors were compared  in terms of their capacity  to increase  bacterial 
growth in the livers of normal recipients over a 3 day period, it was found (Fig. 5) 578  SUBVERSION  OF  HOST  DEFENSE  MECHANISMS.  II 
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FIo.  4.  Evidence that a  suppressor factor persisted in circulation for at least 9 days of 
tumor growth. An intraperitoneal infusion of 0.2 ml of tumor-bearers' serum collected at 
any of the times indicated after implanting tumor cells, suppressed the capacity of normal 
recipients to resist sublethal Listeria infection. Means of five mice per time point. 
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Fro.  5.  Additional evidence that 9-day tumor bearers contained a  suppressor factor in 
circulation.  A  0.2  ml  infusion of 9-day  as  well  as  1-day  tumor-bearers' serum  caused 
continuous bacterial growth for 3 days in the livers of normal recipients. Means -+ SE of  five 
mice per time point. 
that 0.2  ml of 9-day serum as well as 0.2 ml of 1-day serum caused enhanced 
bacterial growth over this period. It can be concluded, therefore, that in spite of 
conversion from a  state of negative to a  state of highly positive antibacterial 
resistance, a  suppressor of antibacterial resistance persisted in circulation. 
Failure  of Allogeneic  and  Lethally  Irradiated  Tumor  Cells  to  Cause  En- 
hanced Antibacterial  Resistance.  It was important for the design  of future 
experiments to  know whether the  suppressed  antibacterial resistance  which 
results  from  subcutaneous  injection of lethally irradiated  tumor  cells  or  of 
allogeneic tumor cells (1) is also followed by a  state of enhanced antibacterial 
resistance.  The  possibility  that  increased  bacterial  resistance  might  fail  to 
develop is suggested by the knowledge that lethally irradiated tumor cells cause 
no tumor growth, and that aUogeneic tumor cells result in only a limited period 
of tumor growth. This question was investigated by an experiment that involved 
measuring changes against time in resistance to a Listeria challenge infection of 
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Fro.  6.  Evidence that implantation of lethally irradiated or allogeneic tumor cells failed 
to result in the generation of a state of increased antibacterial resistance.  In both cases, the 
state of severely suppressed resistance to a Listeria challenge that occurred after implanta- 
tion of tumor cells was followed by a return to normal  levels of antibacterial resistance. 
Means of five mice per time point. 
ated  SA1  cells  as  a  semisyngeneic  tumor,  or  with  106  Meth  A  cells  as  an 
allogeneic tumor. Changes in anti-Listeria resistance were measured by the 24- 
h  growth assay described above. 
It was found (Fig.  6) that although lethally irradiated tumor cells caused a 
short-lived state of suppressed antibacterial resistance, there was no subsequent 
conversion to a  state of increased antibacterial resistance.  Instead, the level of 
antibacterial resistance returned to normal by day 5. Fig. 6 shows that a similar 
result was obtained with an allogeneic tumor, the early rejection of which was 
associated  with  a  return  to a  normal level of antibacterial  resistance.  Taken 
together,  these  results  indicate  that  the  generation  of a  state  of increased 
antibacterial resistance depends on progressive growth of the primary tumor. 
Changes  in  Antibacterial  Resistance  Reflect  Changes  in  Resistance  to  the 
Tumor Itself.  The experiments presented in this section were designed to test 
the prediction that changes  in the level of antibacterial  resistance that  occur 
during growth of a  primary tumor are the result of changes in the level of host 
resistance to the tumor itself.  This prediction was tested by injecting (AB6)F~ 
mice subcutaneously in the right-hind foot pad with 106 SA1 cells, and measur- 
ing  their  capacity  at  progressive  times  thereafter  to  resist  the  growth  of a 
challenge of 5 ×  l0  S tumor cells given either subcutaneously in the contralateral 
foot pad, or intraperitoneally. 
The results  obtained  with the  subcutaneous  challenge are  shown  in Fig.  7 
where  it  can  be  seen  that  initiation  of a  subcutaneous  primary  tumor  first 
resulted  in  a  short-term  state  of suppressed  resistance  as  evidenced by "en- 
hanced growth" of a challenge given on day 3, and then in a contrasting state of 
greatly increased resistance as evidenced by a striking suppression of growth of 
the  same  challenge  given  on  days  6  or  9.  The  timing  of the  change  from 
suppressed to enhanced antitumor resistance thus shows a striking concordance 
with the change from suppressed to enhanced antibacterial resistance (Fig. 1). 580  SUBVERSION  OF  HOST  DEFENSE  MECHANISMS.  II 
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FIG.  7.  Evidence  that  subcutaneous  implantation  of 10  '~ SA1 cells first resulted  in a  state 
of suppressed  resistance  ("enhanced  growth")  to  a  subcutaneous  10  '~ challenege  of tumor 
cells, and then in a contrasting  state of increased resistance to a challenge  of the same cells. 
Means  of five  mice  per time  point. 
The same time relationship was found when the peritoneal cavity was used to 
test for antitumor resistance.  It can be seen in Fig.  8 that whereas the period 
that immediately  followed initiation of the primary  subcutaneous tumor was 
characterized by a state of greatly reduced resistance to growth of the intraperi- 
toneal tumor cell challenge Cenhanced" [3H]TdR  incorporation), this was soon 
followed by the development of a powerful mechanism of resistance to the same 
challenge (suppressed [3H]TdR incorporation). Differences between the control 
and experimental groups on day 3 of the assay are plotted at the bottom of Fig. 8 
to show more clearly the time-course of conversion from suppressed to enhanced 
resistance. ROBERT  J.  NORTH,  DAVID  P.  KIRSTEIN,  AND  RICHARD  L.  TUTTLE  581 
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FZG. 8.  Conversion from negative to positive  resistance  to an intraperitoneal  tumor cell 
challenge.  The  3-day [3H]TdR  incorporation  curves (top  graph) show  that  an  intraperitoneal 
challenge of  tumor cells  underwent "enhanced growth" (increased  [3H]TdR incorporation) 
when injected  either  at  the  time  of,  or  I  day  after  initiating  a subcutaneous  primary  tumor. 
In  contrast,  growth  of  the same  challenge  was  suppressed (decreased  [3H]TdR  incorporation) 
when given  at  later  times.  The bar  graph plots  the 3-day differences  in  [3H]TdR incorpora- 
tion  between tumor-bearing  and control  mice in order  to  better  illustrate  conversion from 
suppressed to enhanced antitumor resistance.  Means of  five  mice per time point. 
It will be noted that the switch from negative to positive antitumor resistance 
occurred  faster  according  to  the  peritoneal  assay.  It  should  be pointed  out, 
however, that additional experiments have revealed that the speed at which the 
switch occurs depends on the number of tumor cells used to initiate the primary 
tumor and the number used for challenge. 
Discussion 
The results of this study confirm those of the preceding study (1) which showed 
that  subcutaneous injection  of murine tumor cells results in rapid and severe 
suppression  of the  capacity of mice to resist  experimental  infection  with  the 
bacterial parasite, L. monocytogenes. The present results show, in addition, that 
the tumor-induced state of suppressed antibacterial  resistance  was short lived 
and was soon replaced by a contrasting state of greatly enhanced antibacterial 
resistance.  Again,  conversion  from  suppressed  to  enhanced  resistance  was 
shown to depend upon progressive growth of the primary tumor,  and to corre- 
spond with conversion from suppressed to enhanced  resistance  to growth of a 
tumor cell challenge.  The results show, therefore, that changes in the level of 582  SUBVERSION  OF  HOST  DEFENSE, MECHANISMS.  II 
antibacterial resistance reflect changes in the level of resistance to the tumor 
itself. This implies that antibacterial resistance and antitumor resistance are 
expressed by a common mechanism of defense. 
The generation of the capacity to strikingly resist the growth of a tumor cell 
challenge  during  rapid  growth  of the  primary  tumor  means  that  the  host 
generated a  state of concomitant antitumor immunity (5), the nature of which 
will  be  dealt  with  in  a  forthcoming publication.  It  can  be  suggested  here, 
however,  that  because  it  appeared  coincidentally with  the  development  of 
macrophage-mediated anti-Listeria resistance, it is almost certain that concomi- 
tant  immunity itself is  expressed  by  activated  macrophages.  This  seems  a 
reasonable suggestion in view of the large body of evidence which shows (6-8) 
that macrophages activated in vivo as a result of microbial infection can recog- 
nize  and  destroy neoplastic  cells  in  a  nonimmunological way  in  vitro.  The 
suggestion is also supported by earlier in vivo findings (9) which showed that 
animals  with  macrophage  systems  activated  as  a  result  of treatment  with 
infectious and noninfectious agents acquire the capacity to retard the growth of 
a tumor cell challenge. The results of this paper show that the converse is true in 
that the response to the tumor itself results in the generation of an activated 
macrophage system. In fact, the results suggest that the level of nonspecific 
macrophage-mediated antibacterial resistance eventually generated in response 
to  the  SA1  sarcoma  is  at  least  equal  to,  or  even  higher  than  the  level  of 
nonspecific antibacterial  resistance  generated  in response  to  an  intravenous 
BCG infection. This is in keeping with publications which show that tumor- 
bearing humans (10) as well as tumor-bearing animals (9) can show an increased 
capacity to clear intravenously injected colloids from their circulation. 
The  present  study lends  more  credence  to  the  view that activated macro- 
phages play an important role in antitumor defense. More direct evidence to 
suggest that concomitant antitumor immunity is expressed by macrophages, 
and  that  it  can  therefore be  expressed  nonspecifically against  antigenically 
unrelated tumors, has recently been reported (11). Our findings serve to empha- 
size the nonspecific nature of the resistance since they clearly show that it is 
expressed against infectious agents. It is not surprising, therefore, that in spite 
of an initial state of severely suppressed antibacterial resistance, death from 
acute  natural  infection is  not a  commonly reported consequence of injecting 
experimental animals with syngeneic tumor cells. 
The coincident development of a state of increased antitumor and antibacte- 
rial resistance is not the only reason for postulating a  common mechanism of 
defense against microorganisms and neoplasia. The postulate is also supported 
by the finding that resistance to both agents is simultaneously suppressed after 
initiating a  primary  tumor.  In  this  case,  however,  a  native  mechanism of 
resistance is  involved. Indeed, it is difficult to escape the conclusion that an 
initial  implant  of tumor cells  survives and  grows  because  of its  capacity to 
rapidly suppress  a  native defense mechanism that would otherwise cause its 
destruction.  Since the  only cells  in the  mouse that can destroy Listeria  are 
macrophages, it seems likely that the suppressor factor described in the preced- 
ing paper (1) serves to protect the primary tumor from destruction by macro- 
phages.  Direct  evidence that tumor-induced suppression  of antitumor resist- ROBERT  J.  NORTH,  DAVID  P.  KIRSTEIN,  AND  RICHARD  L.  TUTTLE  583 
ance,  like  suppression  of antibacterial  resistance,  is  caused  by  a  factor  in 
circulation will appear in a  forthcoming publication. 
In spite of the acquisition of a mechanism of macrophage-mediated resistance 
to a tumor cell challenge, the host remained unable to reject its primary tumor. 
It is highly significant in this connection that the factor which interferes with 
macrophage function continues to be produced and liberated into the circulation 
during growth of the primary tumor. This implies that its most likely source is 
the tumor. If so, it may be present in a large enough concentration in the tumor 
bed to protect the primary tumor from macrophage-mediated antitumor immu- 
nity. It is well to realize that the demonstration of concomitant resistance is an 
artificial procedure in that the introduction of tumor cells with a  needle is in 
itself sufficient to cause a local inflammatory response. It is considered possible 
that this would result in an influx of enough circulating activated mononuclear- 
phagocytes into a  nonvascularized deposit of loose tumor cells to cause tumor 
cell destruction. The conditions in the vascularized bed of a  large established 
tumor, obviously, are quite different from those that exist at the site of a tumor 
cell challenge. 
An additional artificiality in this study was the initiation of growth of trans- 
plantable tumors by subcutaneous injection of 10~-10  ~ cells.  This bears  little 
resemblance  to  the  way  in  which  autochthonous  malignancies  naturally 
emerge. It is therefore right to question the significance to tumor biology of the 
rapid  creation  of the  short-term state  of severely suppressed  antitumor and 
antibacterial resistance that resulted from injection of this comparatively enor- 
mous number of tumor cells. It can be stated in defense of the model, however, 
that it has been  shown in this laboratory (unpublished observations) that  a 
similar degree of suppression occurs after injection of as few as 10  3 tumor cells, 
but  not  until  after a  delay of 2  days.  In  this  case,  moreover,  antibacterial 
resistance remains suppressed for a much longer period of time, a  period that 
corresponds to the period of '~latency" before tumor growth becomes manifest. 
The employment of small numbers of tumor cells for studying the mechanism 
that enables a  small incipient tumor mass to avoid destruction by the host's 
defenses  over  a  long  period  of time  will  be  the  subject  of a  paper  now  in 
preparation. 
Summary 
Subcutaneous  injection  of murine  tumor  cells  first  resulted  in  a  state  of 
severely suppressed macrophage-mediated antibacterial resistance and then in 
a  contrasting state of greatly enhanced antibacterial resistance. Whereas, the 
state of  suppressed antibacterial resistance corresponded to a state of suppressed 
resistance to a  tumor cell challenge, the generation of enhanced antibacterial 
resistance corresponded to the acquisition of concomitant antitumor immunity. 
It  was  suggested on the  basis  of this  evidence that  changes  in  the  level of 
macrophage-mediated antibacterial resistance that occur during growth of the 
primary tumor reflected changes in the level of the host's resistance to the tumor 
itself. It was further suggested that the coincidental suppression of antibacterial 
and antitumor resistance that occurs during the initial stages of growth of the 
primary tumor represents the operation of a mechanism that enables the tumor 584  SUBVERSION  OF  HOST  DEFENSE  MECHANISMS.  II 
to avoid destruction by macrophages. The results support the view that macro- 
phages play an important role in native and acquired resistance to malignant 
tumors. 
Received for publication 26 November 1975. 
References 
1.  North,  R.  J.,  D.  P.  Kirstein,  and  R.  L.  Tuttle.  1976. Subversion  of host  defense 
mechanisms by murine tumors. I. A circulating factor that suppresses macrophage- 
mediated resistance to infection. J. Exp. Med.  143:000. 
2.  North, R. J. 1974. Cell-mediated immunity and the response to infection. In Mecha- 
nisms of Cell-Mediated  Immunity.  R.  T.  McCluskey and S.  Cohen,  editors.  John 
Wiley & Sons, Inc., New York and London,  185. 
3.  Robinette,  E.  H.  and  D.  N.  Mardon.  1975. Delayed  lethal  response  to  Candida 
albicans infection in mice bearing the Lewis lung carcinoma. J. Natl.  Cancer Inst. 
55:731. 
4.  Fioretti,  M.  C.,  M.  Liberati,  E.  Bonmassar,  and  G.  Cudkowicz.  1975. Immune 
inhibition of allogeneic lymphoma cells in the peritoneal cavity of mice. Cancer Res. 
35:30. 
5.  Bashford, E. F. 1908. Third Scientific Report of the Imperial Cancer Research Fund. 
Taylor & Francis Ltd., London, England.  262. 
6.  Keller, R. 1974. Mechanisms by which activated normal macrophages destroy synge- 
neic rat tumor cells in  vitro:  cytokinetics,  noninvolvement of T  lymphocytes, and 
effect of metabolic inhibitors. Immunology.  27:285. 
7.  Hibbs, J. B., L. H. Lambert, and J. S. Remington. 1972. In vitro non-immunological 
destruction  of cells  with  abnormal  growth  characteristics  by adjuvant  activated 
macrophages. Proc. Soc. Exp. Biol. Med.  139:1049. 
8.  Germain, R. N., R. M.  Williams, and B. Benacerraf.  1973. Specific and nonspecific 
antitumor immunity. II. Macrophage-mediated nonspecific effector activity induced 
by BCG and similar agents. J. Natl. Cancer Inst.  54:709. 
9.  Old, L. J., D. A. Clark, B. Benacerraf, and M. Goldsmith. 1960. The reticuloendothe- 
lial system and the neoplastic process. Ann. N.  Y. Acad. Sci.  88:264. 
10.  Maganey, C.  J.,  and M.  Baum.  1970. Reticuloendothelial  activity in humans with 
cancer. Br. J. Surg.  57:748. 
11.  Kearney,  R.,  A.  Basten,  and  D.  S.  Nelson.  1975. Cellular  basis for the  immune 
response to methycholanthrene-induced tumors in  mice.  Heterogeneity of effector 
cells. Int. J. Cancer.  15:438. 